StonvexLoading…
StonvexStonvexStonvexCore line items from ANGI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.03B | $1.19B | $1.36B | $1.76B |
Operating Income | $65.41M | $21.89M | $-26.50M | $-75.62M |
Net Income | $43.83M | $36.85M | $-40.31M | $-127.98M |
EPS (Diluted) | $0.94 | $0.71 | $-0.81 | $-0.26 |
Total Assets | $1.68B | $1.83B | $1.86B | $1.91B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $303.70M | $416.43M | $364.04M | $321.15M |
Free Cash Flow OCF − CapEx | $45.47M | $105.45M | $46.40M | $-88.41M |
Shares Outstanding | 46.45M | 50.67M | 50.59M | 503.01M |